Enterprise Value
445.8M
Cash
525.9M
Avg Qtr Burn
-19.24M
Short % of Float
33.87%
Insider Ownership
3.50%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
4D-150 Details Wet age-related macular degeneration | Phase 2 Data readout | |
4D-150 Details Diabetic macular edema | Phase 2 Data readout | |
4D-310 Details Fabry disease | Phase 1/2 Data readout | |
4D-125 Details X-linked retinitis pigmentosa | Phase 1/2 Data readout | |
4D-710 Details Cystic fibrosis | Phase 1/2 Data readout | |
4D-110 Details Choroideremia | Phase 1 Data readout | |
4D-175 Details Geographic atrophy | Phase 1 Initiation |